Kronos Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$112,673,000 and profit margin reached -1792%. Total operating expenses were $128,118,000.

Profit Margin

Kronos Bio, Inc. (NASDAQ:KRON): Profit margin
2018 0 -6.72M
2019 0 -15.41M
2020 0 -64.08M
2021 0 -149.10M
2022 0 -129.29M
2023 6.28M -112.67M -1791.87%

KRON Income Statement (2018 – 2023)

2023 2022 2021 2020 2019 2018
Revenue
Revenue
6.28M00000
Cost of revenue
04.46M4.08M4.86M605K0
Gross profit
6.28M-4.46M-4.08M-4.86M-605K0
Operating exp.
Research and development
86.37M93.71M112.90M43.25M13.44M5.03M
Selling and marketing
000000
Total operating expenses
128.11M137.11M151.39M58.04M16.81M6.64M
Operating income
-121.83M-137.11M-151.39M-58.04M-16.81M-6.64M
Other income (expenses), net
9.15M3.91M320K-30.4M699K-76K
Income before tax
-112.67M-133.20M-151.07M-88.44M-16.11M-6.72M
Income tax expense
0-3.91M-1.97M-24.35M-699K0
Net income
-112.67M-129.29M-149.10M-64.08M-15.41M-6.72M
Earnings per share
Basic EPS
-1.95-2.3-2.72-1.19-0.29-0.24
Diluted EPS
-1.95-2.3-2.72-1.19-0.29-0.24
Data sourceData sourceData sourceData source